Bacteraemia Is Associated with Increased ICU Mortality in the Postoperative Course of Lung Transplantation

Archive ouverte

Tran-Dinh, Alexy | Guiot, Marion | Tanaka, Sébastien | Lortat-Jacob, Brice | Atchade, Enora | Zappella, Nathalie | Mordant, Pierre | Castier, Yves | Mal, Hervé | Weisenburger, Gaelle | Messika, Jonathan | Grall, Nathalie | Montravers, Philippe

Edité par CCSD ; MDPI -

International audience. We aimed to describe the prevalence, risk factors, morbidity and mortality associated with the occurrence of bacteraemia during the postoperative ICU stay after lung transplantation (LT). We conducted a retrospective single-centre study that included all consecutive patients who underwent LT between January 2015 and October 2021. We analysed all the blood cultures drawn during the postoperative ICU stay, as well as samples from suspected infectious sources in case of bacteraemia. Forty-six bacteria were isolated from 45 bacteraemic patients in 33/303 (10.9%) patients during the postoperative ICU stay. Staphylococcus aureus (17.8%) was the most frequent bacteria, followed by Pseudomonas aeruginosa (15.6%) and Enterococcus faecium (15.6%). Multidrug-resistant bacteria accounted for 8/46 (17.8%) of the isolates. The most common source of bacteraemia was pneumonia (38.3%). No pre- or intraoperative risk factor for bacteraemia was identified. Recipients who experienced bacteraemia required more renal replacement therapy, invasive mechanical ventilation, norepinephrine support, tracheotomy and more days of hospitalization during the ICU stay. After adjustment for age, sex, type of LT procedure and the need for intraoperative ECMO, the occurrence of bacteraemia was associated with a higher mortality rate in the ICU (aOR = 3.55, 95% CI [1.56–8.08], p = 0.003). Bacteraemia is a major source of concern for lung transplant recipients.

Suggestions

Du même auteur

Impact of Culture-Positive Preservation Fluid on Early Morbidity and Mortality After Lung Transplantation

Archive ouverte | Tran-Dinh, Alexy | CCSD

International audience. The prevalence, risk factors and outcomes associated with culture-positive preservation fluid (PF) after lung transplantation (LT) are unknown. From January 2015 to December 2020, the microbi...

Secondary prophylaxis with inhaled colistin to Prevent recurrence of pseudomonas aeruginosa and extended-spectrum β-lactamase-producing enterobacterales eneumonia in ICU After lung Transplantation: A before-and-after retrospective cohort analysis

Archive ouverte | Tran-Dinh, Alexy | CCSD

International audience. Background. Early pneumonia is an independent risk factor for 1-y mortality after lung transplantation (LTx). Pseudomonas aeruginosa is the most common isolate in early pneumonia and is also ...

No Emergence of Colistin Resistance in the Respiratory Tract of Lung Transplant Patients Treated With Inhaled Colistin

Archive ouverte | Grall, Nathalie | CCSD

International audience. Secondary prophylaxis using inhaled colistin (IC) was implemented to prevent recurrences of Pseudomonas aeruginosa or extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) pneumo...

Chargement des enrichissements...